Acting Director of the Division of Global HIV/AIDS (DGHA): John Blandford, PhD
Dr. John Blandford, PhD serves as the Acting Director of the Division of Global HIV/AIDS (DGHA) at the U.S. Centers for Disease Control and Prevention (CDC). His position of record is Principal Deputy Director of DGHA. CDC is one of six key implementing agencies whose global HIV/AIDS work supports the President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to combat a single disease globally. Dr. Blandford oversees the management of CDC’s global HIV treatment, care and prevention programs and the division’s more than 1,800 staff positioned in 44 country offices and headquarters in Atlanta. Dr. Blandford also serves as a PEPFAR Deputy Principal, providing overall leadership in strategy and management for PEPFAR.
Dr. Blandford served as Chief of DGHA’s Health Economics, Systems, and Integration Branch for two years after he launched the branch in 2010. His leadership was critical in elevating the role of economic research and analysis to support planning, sustainable scale-up and efficient implementation of global HIV programs under PEPFAR. He directed and was principal investigator of the PEPFAR ART Costing Project, a multi-country study of costs and cost drivers of global HIV treatment programs, and pioneered the initial design and piloting of PEPFAR Expenditure Analysis, which has been adopted for routine implementation across PEPFAR to support program management, accountability and efficiency. For two years, Dr. Blandford was seconded to the Department of State’s Office of the U.S. Global AIDS Coordinator, where he oversaw implementation science activities across multiple U.S. government agencies and guided efforts to project global resource needs for scale-up of PEPFAR programs.
Dr. Blandford studied at the University of Texas-Austin and the University of Notre Dame, and conducted his postdoctoral research at the University of Chicago as a Social Science Research Council Fellow. He came to CDC in 2001 as a Prevention Effectiveness Fellow in the Division of Sexually Transmitted Diseases.